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INFLUENCE OF VEIN VALVES 
IN THE DEVELOPMENT OF 
ARTERIOSCLEROSIS IN 
VENOARTERIAL GRAFTS 
IN THE RABBIT 
Coronary saphenous vein grafts in human beings have a more limited 
long-term patency rate than internal thoracic artery grafts, primarily 
because of more rapid development ofarteriosclerosis. The factors respon- 
sible for this increased susceptibility are not completely understood. To test 
the hypothesis that vein valves may influence this process, we studied 48 
hypercholesterolemic rabbits with jugular vein grafts interposed into the 
carotid arterial circulation. In 24 animals (group A), the vein segments did 
not contain a vein valve. In the other 24 animals (group B), a vein valve was 
present. Both groups were further divided in four subgroups of six to be put 
to death at 2, 4, 6, and 8 weeks after the operation. All animals were fed a 
2% cholesterol diet. At postmortem examination, alternate 2 mm sections 
were either stained with hematoxylin and eosin for histologic and morpho- 
metric studies or frozen in liquid nitrogen for immunohistochemistry and
in situ hybridization studies. Proliferating cell nuclear antigen immuno- 
staining was used to study cell proliferation. Wall thickness of vein grafts 
increased with time. During the first 2 weeks intimal and medial thickening 
was primarily due to an increase in numbers of cells. Between 2and 6 weeks 
further intimal and medial thickening occurred, but without additional 
increase in cell numbers. After 6 weeks, foam cells and lipid deposits 
started to appear. By 8 weeks, changes identical to those seen in arterio- 
sclerotic plaques in human beings were evident. These changes developed 
sooner and with more intensity in group B animals (p < 0.01 to 0.001), and 
they developed faster and with more severity in segments of vein located 
distal to the valve than in the segments located proximal to the valve (p < 
0.001). This is the first controlled experiment demonstrating that the 
presence of valves in the vein segments i associated with augmented and 
accelerated intimal changes leading to vein atheromatosis. (J THORAC 
CARDIOVASC SURG 1995;110:1381-90) 
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T he reported patency rate of human saphenous vein grafts is variable, but it is generally accepted 
that the rate is about 80% to 90% at 1 year and 50% 
to 70% at 7 to 10 yearsJ' 2 The changes leading to 
vein graft occlusion in human beings have been 
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classified as acute (<1 month), subacute (1 to 2 
months), intermediate (1 to 5 years), and long term 
(>5 years)) The acute and subacute changes are 
attributed to thrombosis or intimal thickening. In- 
termediate and long-term changes are due to devel- 
opment of arteriosclerosis-like l sions. Intimal 
changes in experimental venoarterial graft models, 
including the effect of hyperlipidemia, have been 
studied in the rabbit, 4as well as in dogs and rhesus 
monkeys. 5-8 The contribution of vein valves to the 
development of these changes has been suspected 
for some time. 9-12 This series of experiments was 
designed to study, in a controlled fashion, the pos- 
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Table I. Distribution of  the 48 New Zealand White 
rabbits 
Group A (No.): Group B (No.): Postmortem xam 
No valve present Valve present time (wk) 
6 6 2 
6 6 4 
6 6 6 
6 6 8 
24 24 
sible effect of vein valves on vascular wall thickening 
and subsequent atheromatous vein graft changes in 
a model  of accelerated arteriosclerosis in the rabbit. 
Methods 
Animal model. The rabbits in this study were fed a diet 
containing 2% cholesterol, starting 1 week before the 
operation and continuing throughout the experiment. To 
determine the possible ffect of vein valves on the devel- 
opment of intimal thickening and on the formation of 
arteriosclerosis-like lesions, we implanted autologous jug- 
ular vein grafts into the common carotid artery of 48 New 
Zealand White rabbits with weights between 3 and 3.5 kg. 
In 24 animals (group A), a segment of the jugular vein that 
did not contain a valve was used. In another 24 rabbits 
(group B), the segment of vein contained a vein valve, 
which is consistently found in the rabbit at the junction 
between the external and internal jugular veins. This valve 
can be easily identified by visual inspection and injection 
of heparinized saline solution in the direction opposite the 
blood flow. All animals were anesthetized with a 4 mg/kg 
concentration of ketamine and a 2 mg/kg concentration of
xylazine mixed in a bolus injection. A drip of 200 mg of 
ketamine and 40 mg of xylazine in 250 ml of normal saline 
solution was used for maintenance of anesthesia. 
The external and internal jugular veins were exposed on 
one side of the neck after systemic heparinization (3 mg/kg). 
The vein was removed and flushed with heparinized saline 
solution (10 mg in 1000 ml normal saline solution). The vein 
that had been marked for orientation was reversed at the 
time of implantation. The carotid artery was exposed and 
clamped proximally and distally. With the use of surgical 
magnification and continuous 8-0 polypropylene sutures, 
end-to-side anastomoses were performed istally and prox- 
imally. The carotid artery was tied close to both anastomoses 
and divided in between. The average length of the grafts was 
2 cm. Animal care complied with the "Guide for the Care 
and Use of Laboratory Animals" prepared by the Institute of 
Laboratory Animal Resources and published by the Na- 
tional Institutes of Health (NIH Publication No. 86-23, 
revised 1985). 
Groups A and B were each further subdivided into four 
groups of six animals and killed at 2-week intervals (Table 
I). To obtain the desired number of animals in each group, 
we had to operate on a total of 63 rabbits. Fifteen could 
not be used, 12 because they had clotted grafts at post- 
mortem examination (19% occlusion rate) and three 
Table II. Immunochemistly protocol 
Antiserum Specificity Dilution 
Monoclonal mouse Smooth muscle 1:50 
antihuman c~-smooth 
muscle actin 
Monoclonal mouse Macrophages 1:100 
antihuman macro- 
phage, CD68 
Anti-PCNA/cyclin Proliferating cells 1:80 
mouse monoclonal 
antibody lgG 24 
IgG, Immunoglobulin G. 
because of problems with tissue processing. Occlusion 
rate was due to surgical technical mistakes during the 
learning curve; graft occlusions occurred rarely thereafter. 
Additionally, six other animals were operated on for the 
purpose of studying the very early changes that occur in 
the vein wall; three were put to death at 3 days and three 
at 7 days. These six animals constitute a separate group in 
which the quantitative morphometric studies were not 
carried out, and only histologic and immunohistochemical 
studies were performed. Before being killed, the animals 
were anesthetized as described earlier; the grafts were 
dissected from the surrounding tissues and removed to- 
gether with segments of carotid artery attached proximally 
and distally. After being flushed with heparinized saline 
solution, the distal end of the artery was tied and the graft 
distended with 4% paraformaldehyde until the diameter 
was approximately the same as in vivo. The proximal end 
of the artery was then tied, and the specimen was im- 
mersed in 4% paraformaldehyde solution for 1 hour. The 
tissue was then washed with a solution of 15% sucrose and 
immersed in the same solution for 12 hours. Next, 2 mm 
cross sections were obtained, and alternate sections were 
either further fLxed in 10% formalin for morphologic 
analysis or immediately frozen in O.C.T. compound 
(Miles, Inc., Elkhart, Ind.) and dry ice for storage at 
-70  C to be used for immunohistochemical and in situ 
hybridization studies. 
The immunohistochemical studies were performed 
with commercially available antisera and a standard 
Avidin-Biotin LS AB 2 kit (Dak Laboratories, Carpen- 
teria, Calif.). Table II shows the antisera, their speci- 
ficity, and the dilutions used. For negative control 
studies, the primary antisera were deleted from the 
procedure. Positive controls consisted of tissue known 
to contain the target antigens (human intestine and 
tonsil). 
Morphometry. The normal structure of the jugular vein 
in the New Zealand White rabbit consists of a single layer 
of endothelial cells, a very narrow medial layer formed 
mainly by smooth muscle cells, and a wider adventitial 
layer formed mainly of collagen with few scattered smooth 
muscle cells. The internal elastic lamina is scattered and 
difficult to identify consistently. Given these facts, we 
decided, for the purpose of these studies, to make all the 
measurements of wall area and wall thickness from the 
lumen to the limit between media and adventitia. This 
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Table III. Comparison of mean thickness~area between group A (n = 24) and group B (n ~= 24) 
Wall thickness (pro) Wall area (tzm/mm) 
Group A Group B p Group A Group B p 
Weeks (mean +- SEM) (mean +_ SEM) Value (mean +_ SEM) (mean +_ SEM) Value 
2 70.3 -+ 5.6 96.5 -+ 8.3 NS 72.8 -+ 5.3 95.5 +- 6.3 NS 
4 128.9 +- 14.1 183.0 -+ 19.7 <0.01 127.1 -+ 13.8 183.4 -+ 21.6 <0.006 
6 165.7 -+ 7.1 257.3 +_ 11.6 <0.001 166.7 -+ 5.8 255.4 + 14.4 <0.001 
8 202.5 -+ 17.9 266.5 -+ 14.4 <0.01 202.9 + 16.2 266.9 _+ 12.6 <0.01 
SEM,, Standard error of the mean; NS, not significant. 
limit was consistently clear and easy to identify. Mean wall 
thickness was determined by taking measurements in 
micrometers at four equidistant sites, 90 degrees from 
each other, around the vessel perimeter. Mean area was 
defined as the total area encompassed within the vessel 
wall (excluding the adventitia) minus the luminal area; the 
units of measurement were micrometer squared. 
Measurements of intimal and medial thickness, luminal 
and intimai circumference, and intimal area were ob- 
tained with a calibrated, computer-based, image-measur- 
ing software system (Optimas, BioScan, Inc., Edmonds, 
Wash.), on magnified images relayed from a microscope- 
mounted video camera to a monitor. This method was 
validated by manual planimetry in 70% of the animals, 
with good correlation between both methods. 
Immunohistochemistry. Data on cell kinetics were ob- 
tained from immunohistochemistry staining for prolifer- 
ating cell nuclear antigen (PCNA). This method yields an 
estimation of the number of cells actively dividing at a 
given time. as' 14 Nuclear counting was done with a light 
microscope at 20× magnification with a computer-based 
image analyzer (Optimas). Proliferating cells were defined 
as those that stained as intensely as central intestinal crypt 
epithelium at the intimal and medial levels. Cell density 
was defined as the total number of cells encountered in 
the intima and the media per millimeter. 
Statistical analysis. Mean area and thickness were 
compared between sections located in the middle of the 
grafts in group A and sections located immediately after 
the valve in group B animals, by means of analysis of 
variance and BMDP software (BMDP Software, Los 
Angeles, Calif. ) . The model was specified such that mean 
area and mean thickness were the dependent variables; 
the independent variables were presence or absence of 
valves in the vein grafts and time in weeks from the 
operation. Contrasts were used to test for differences 
between groups A and B for each period. Plots of mean 
area and thfckness for the two groups over time were also 
carried out. 
In group B animals, measurements of area and thick- 
ness were made at vein cross sections just before and just 
after the valve. The difference between sections was 
calculated and tested by a paired t test. Additionally, 
regression analysis was used to test for trends across 
evaluation times. Plots of mean and standard error for the 
difference between areas and thickness proximal and 
distal to the valves were also performed. 
Results 
The highly concentrated cholesterol diet was well 
tolerated, and serum cholesterol levels rose rapidly 
to a mean value of 1932 mg/dl before the animals 
were killed. 
Morphology and immunohistoehemistry. Vein 
grafts implanted in the carotid arterial circulation 
became progressively thicker as time elapsed and 
reached a maximum thickness at 8 weeks (Table 
III). This thickening was due to proliferation of 
spindle-shaped cells with histologic and immuno- 
histochemical (actin positive) features of smooth 
muscle cells, as well as a matrix composed of 
collagen, elastic tissue, and acid mucopolysaccha- 
rides. At 2 weeks after implantation of the vein 
grafts, intimal and medial thickening was associ- 
ated with an increase in cell number (Fig. 1, A). At 
4 weeks, the number of cells started to decrease, 
and further increase in thickness was associated 
with increased extracellular matrix. PCNA expres- 
sion showed that cell proliferation starts as early 
as 3 days, remains active at 2 weeks, is only 
minimal at 4 weeks, and is nonexistent at 6 and 8 
weeks (Fig. 1, B). 
Fig. 2 shows representative s ctions of veins at the 
different imes studied. In normal, control veins the 
media consisted of only a few layers of smooth 
muscle cells of negligible thickness. By 2 weeks, the 
media was thickened by a proliferation of tightly 
packed spindle cells. At 4 weeks, some regions 
showed less cellularity, with a light pink matrix 
present. This was also present at 6 weeks when a 
definite increase in pink collagen was observed 
within the media. In some cases, after longer dura- 
tions of implantation, cells with clear abundant 
cytoplasm (foam cells) were present. These cells had 
histologic and immunohistochemical features of 
macrophages. In these veins, extracellular lipid was 
also observed. 
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Fig. 1. A, Cell density (number of cells per square micrometer) was largest at 2 weeks and progressively 
decreased during the time of the experiment. B, PCNA expression reached amaximum at 2 weeks, and it 
was minimal or nonexistent thereafter. No difference was detected between the two groups. 
Fig. 3 shows the changes that were observed in the 
valves when these were present in the implanted 
veins. As early as 3 days after implantation, thick- 
ening and increased cellularity were observed, most 
prominent at the base of the valves. Early on, these 
were primarily spindle cells with features of smooth 
muscle cells. Later, extracellular matrix was depos- 
ited with prominent collagenous tissue present. 
Foam cells and extracellular lipid were also observed 
on the valves after longer periods of implantation. 
Fig. 4 shows the results of the immunohistochem- 
ical studies performed. Within the valves PCNA 
staining showed prominent cell proliferation as early 
as 3 days after implantation. This prolifiration de- 
creased with time. On the other hand, vein media 
away from valves showed most pronounced cell 
proliferation 2 weeks after implantation. The medial 
spindle-shaped cells and PCNA-positive cells stained 
positively for smooth muscle-specific a tin, confirm- 
ing their smooth muscle cell differentiation. The 
foam cells present stained positively with monoclo- 
nal mouse antihuman macrophage, CD68 anti- 
serum. Thus, whereas the early changes consisted 
primarily of smooth muscle cell proliferation, a 
common response of the vascular wall to injury, late 
changes that included macrophages and extracellu- 
lar lipid deposition were more typical of atheromas. 
Morphometry. The changes described herein oc- 
curred to a certain degree in both study groups of 
animals. We made morphometric measurements to 
quantify these changes and to assess whether there 
were any differences between the groups, with re- 
spect to severity or to the time necessary for the 
lesions to develop. Analysis of variance for wall 
thickness or for wall area measurements between 
segments corresponding tothe middle of the graft in 
group A animals and for segments located immedi- 
ately after the valve in group B animals (see Table 
III) failed to show any significant difference at the 
2-week period. It was at this time that most of the 
proliferation of cells, as shown by the expression of 
PCNA, took place, as well as when the cell density 
was at the highest level. However, no significant 
differences between groups A and B in the cell 
kinetic studies were noted. From this period on, 
increases in wall thickness and area were greater for 
group B than group A animals at 4, 6, and 8 weeks. 
A paired t test, used to identify significant differ- 
ences between mean wall thickness and area of vein 
cross sections taken immediately before and after 
the valve in group B animals (Table IV), showed 
that measurements were consistently and signifi- 
cantly higher for the sections located after the valve 
for all time periods, including 2 weeks. 
Discussion 
The saphenous vein continues to be an essential 
component of surgical myocardial revascularization 
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Fig. 2. Media: Photomicrographs at a standard original magnification of 50× showing progressive increase 
in medial thickness of veins with time that occurred in both treatment groups. A, Control; B, 2 weeks; C, 
4 weeks; D, 6 weeks, E and F, 8 weeks. Note in E that at 8 weeks the media was sometimes more fibrous 
and less cellular and, as shown in F, sometimes contained numerous foamy macrophages (asterisks). a, 
adventitia; m, media. (Hematoxylin and eosin stain.) 
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Fig. 3. Valve: Photomicrographs demonstrating venous valvular changes. A, B, and C are normal valves 
(open arrows) at 10×, 25×, and 50× magnification; D, E, and F are valves from veins implanted for 2 to 
6 weeks, shown at 10×, 25×, and 50× magnification. Note the marked thickening of the valve base. In E 
this consists primarily of smooth muscle cells. In F foamy macrophages (a terisks) are also present. D, E, 
and F also demonstrate medial proliferation f the adjacent venous wall (small arrows). (Hemato~lin and 
eosin stain.) 
Fig. 4. Immunohistochemistry: Photomicrographs showing results of immunohistochemical studies. A, 
Hematoxylin and eosin stain of valvular proliferation at 3 days (50 ×). B, PCNA staining showing numerous 
positive brown-staining cells (arrows). Inset shows positive control consisting of intestinal crypt epithelium 
(50x). Adjacent media had little PCNA positivity. C, Valve at 4 weeks showing no PCNA positivity. D, 
Example of vein wall proliferation of cells (PCNA positivity indicated by arrows) obselwed within the first 
2 weeks after implantation (100×). E, An example of staining of the venous wall at 2 weeks for smooth 
muscle cell(s), specific actin indicating that virtually all the cells are smooth muscle cells (10×). F, a vein 
at 8 weeks, with primarily foam cells in the wall (hematoxylin and eosin stain, 10×). G, Most foam cells are 
negative for smooth muscle-specific actin(s) (100x). H, Another vein showing that foam cells stain 
positively with a macrophage-specific antibody (red), whereas mooth muscle cell(s) fail to stain (100×). 
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Table IV. Difference between thickness/area proximal and distal to the vein valve (~vup B, n = 24) 
Proximal Distal Difference 
Weeks No. (mean) (mean) (mean +_ SEM) p Value 
Thickness (/~m) 
Area (/xm/mm) 
2 6 63.0 96.5 33.4 _+ 5.4 <0.001 
6 6 147.6 183.4 35.4 2 8.2 <0.008 
4 6 210.1 257.3 47.2 ~ 3.8 
8 6 210.5 266.5 56.0 ± 14.0 <0.01 
2 6 61,5 95.5 34.1 ± 4.6 <0.001 
6 6 146.3 183.4 37.1 ± 6.9 <0.003 
4 6 212.8 255.4 42.6 + 4.4 
8 6 215.8 266.9 51.3 + 18.5 <0.04 
strategies in human beings. It is the most commonly 
used conduit, alone or in combination with arterial 
grafts. Saphenous vein has the advantage of being 
autologous vascular tissue available in the majority 
of patients in need of this operation. It has been 
known for decades that the main limitation of 
saphenous vein grafts is the propensity for the 
development of sclerotic changes imilar to those 
seen in the arterial circulation. 1 In our clinical 
practice, we have been intrigued by the observation 
that in patients returning for angiography years after 
surgery, some grafts are completely occluded or 
have severe atheromatous changes, whereas others 
remain perfectly clean and patent. Because these 
grafts were performed at the same time and have 
been subjected to presumably similar physiologic 
and identical metabolic onditions, we have postu- 
lated that some intrinsic morphologic characteristics 
could be different in the segments used for multiple 
bypasses inthe same patient, and that this difference 
in morphologic features could, at least in part, 
explain the differences in long-term outcomes. Pres- 
ence of valves in vein segments has been suspected 
as being one of the morphologic factors influencing 
formation of atheromatous le ions, m-12 
In vitro studies have demonstrated mechanisms 
by which these valves may influence the hemody- 
namic flow characteristics of blood through the 
veins, j5-17 implicating the valves in the development 
of proliferative lesions. Noncontrolled animal ex- 
periments by Bosher and associates is have sug- 
gested that in vivo vein valves could also play a role. 
The next logical step, then, was to develop an animal 
model that could either refute or confirm these 
suspicions in a scientifically controlled manner, as 
well as allow for future studies. The animal model 
that we developed iffers from previously described 
New Zealand White rabbit models 19 in two ways: (1) 
the presence or absence of vein valves in the seg- 
ments of internal jugular veins used and (2) the 
cholesterol concentration in the diet received by the 
animals and the serum cholesterol levels achieved, 
which were higher than those previously reported. 4 
This animal model produced changes that devel- 
oped faster in the wall of the vein graft, thus 
reducing the duration and cost of the project. These 
changes were increased proliferation of smooth 
muscle cells during the first 2 weeks after implanta- 
tion, and thereafter an increased extracellular ma- 
trix formed mainly by mucopolysaccharides and 
collagen, as well as infiltration of macrophages that 
later turn into foam cells. If the grafts are left for 
longer periods, deposits of cholesterol crystals, as 
well as calcification, can be noted. When wall thick- 
ness and area were measured, these morphometric 
studies confirmed that the changes develop with 
greater intensity in areas located distal to the vein 
valves. Our previous in vitro studies, 16 as well as 
those performed by Thubrikar, Robicsek, and Fowl- 
er 15 and the work by Davies and colleagues, 2° 
correlated well with the findings of the present study 
and suggest that wall tension, increased turbulence, 
and pressure changes that occur distal to the valves 
could be responsible for the increased formation of 
atheromatous lesions in this area. In addition, 
changes in the diameter of the vein resulting from 
distention produced by the higher arterial pressure 
could also be a factor, as suggested by Zweep and 
coworkers. 2aThe limitations of this animal model as 
compared with human aorta-coronary saphenous 
vein bypasses are due to species differences, differ- 
ences in the structure of the human saphenous vein 
and the jugular vein of the rabbit, and differences in
flow characteristics between the coronary and the 
carotid circulations. 
Despite these limitations, we believe that in hu- 
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man beings, careful planning for surgical myocardial 
revascularization perations can result in the elimi- 
nation of several veins valves from the segments 
chosen to bypass the coronary arteries. This, to- 
gether with optimal management of risk factors 
after revascularization, z2 may result in prolonged 
patency of the venous grafts. Unfortunately, how- 
ever, when the vein is used to bypass three or more 
arteries, inevitably some valves will remain in at 
least some of the segments. For these reasons, and 
also because all vein grafts will eventually be af- 
fected by atheromatons lesions, it is necessary to 
develop other methods to decrease or eliminate 
these changes. Attention should be paid not only to 
the aspects of cell biology and proliferation, but also 
to the role played by the extracellular matrix. This 
model or similar ones could be used to test these 
new methods. 
We thank Kathteen Farrington and Michele A. De- 
Robertis, RN, for their expertise in the preparation ofthis 
manuscript. 
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Discussion 
Dr. Mano J. Thubrikar (Charlotte, N.C). Dr. Robicsek 
and I have been doing some work with the vein graft, and 
I congratulate Dr. Chaux and his group for their excellent 
study. 
I have three comments. First, inasmuch as the vein 
valve is present at the junction of the internal and external 
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jugular veins, the diameter of the graft distal to the valve 
is likely to be larger than that proximally. Consequently, 
the thickness and the wall area are likely to be greater 
distally. Couldn't his produce different degrees of hyper- 
plasia? 
Second, comparing valveless grafts with valved grafts 
gives the impression that increased atherosclerotic 
changes develop in the entire vein graft, whereas in fact 
the proximal segment of the valved graft shows changes 
similar to those in the graft without the valve. This 
distinction is important. 
Third point: The question should be not only whether 
the valve is present in the graft but whether the valve is 
functional. For instance, as is shown in this slide, on the 
angiogram the valve was closed on the left and open on 
the right, and down below ultrasonic images of the vein 
valve show closed and open positions of the valve. 
When the vein graft is put in the arterial system we 
begin to understand why nature did not put valves in the 
artery. When the mean graft flow decreases, the valve 
cyclically opens and closes much like the aortic valve, and 
suddenly there is a pressure trap distal to the valve just as 
there is a separation of aortic and ventricular pressures. 
Thus the closed valve traps the pressure distally, which 
means it produces a diastolic hypertension. But also, the 
flow trace has a character of the aortic flow, which means 
there is a zero flow period during each cardiac ycle. Thus, 
if the valve is functional, then there is a distal hyperten- 
sion and a stagnation of flow. When the valve is not 
functional, there is still turbulence behind the leaflets. The 
graft thus may exhibit different characteristics depending 
on whether the valve is functional or not. 
In general, I agree with the conclusion that the valve is 
likely to exacerbate atherosclerotic changes. To me the 
important question is not only whether the valve is there 
but whether the valve is functional. 
Dr. Chaux. Thank you for your comments. Let me go 
back to your first question: Yes, there is a difference in 
diameter of the vein, given the presence of a valve at the 
division of the internal jugular vein. This occurs in human 
beings, as well. Frequently there is a difference in the 
diameter of the saphenous vein proximal and distal to a 
valve, and that is one of the reasons that we chose to use 
this model and try to mimic as much as possible the 
conditions in the human coronary grafts. We think that 
the difference in diameter is important in the pathogenesis 
of the lesions. 
With respect to the second issue that you raised, I think 
you are correct. However, this is a hypercholesterolemic 
rabbit model. Eventually arteriosclerotic changes will de- 
velop in the vascular systems of all these rabbits. 
With respect o your comments regarding the function 
of the valve, I am familiar with your work, and I think that 
what you have suggested is a possible mechanism for the 
development of these lesions, but there are other possible 
mechanisms as well. 
Dr. Thomas Z. Lajos (Buffalo, N.Y.). These findings are 
strongly supported by our clinical observations in the past 
12 years. 
We have used the side-to-side aorta-saphenous graft 
since 1970. The valveless limb of the "horseshoe graft" has 
been depicted since 1983, with a 12-year long-term follow- 
up. We have used a valveless egment and a valvular 
segment in the same patient. We have a follow-up on 78 
patients and 306 grafts. There is a trend toward increased 
overall patency of 78.4% in the valveless limb versus 
72.5% in the limb with valves in 12 years' follow-up. 
Comparing the sequential valvular and valveless limbs, 
there is a significant increase in the patency of the 
sequential valveless egment, 88% versus 70.2% (p < 
0.05) in 12 years. Patency of the valveless limb is also 
significantly increased if this valveless egment is directed 
to the left side (81.5% vs 67.8%, p < 0.05). 
I think our data show that the valveless vein segment 
has a higher patency in long-term follow-up then the 
"average" reversed saphenous vein with the valves. 
Dr. Chaux. Thank you very much. We have similar 
clinical observations, and they motivated us to perform 
these experiments in the laboratory and to come up with 
some answers. 
